See more : Venustech Group Inc. (002439.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Accolade, Inc. (ACCD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Accolade, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Big Cypress Acquisition Corp. (BCYP) Income Statement Analysis – Financial Results
- KEI Industries Limited (KEI.BO) Income Statement Analysis – Financial Results
- Amur Minerals Corporation (CRTX.L) Income Statement Analysis – Financial Results
- Bonhill Group Plc (BONH.L) Income Statement Analysis – Financial Results
- Brookside Energy Limited (RDFEF) Income Statement Analysis – Financial Results
Accolade, Inc. (ACCD)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.accolade.com
About Accolade, Inc.
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 414.29M | 363.14M | 310.02M | 170.36M | 132.51M | 94.81M | 76.83M |
| Cost of Revenue | 222.23M | 198.91M | 169.02M | 93.67M | 73.69M | 60.57M | 53.44M |
| Gross Profit | 192.06M | 164.24M | 141.00M | 76.69M | 58.82M | 34.24M | 23.39M |
| Gross Profit Ratio | 46.36% | 45.23% | 45.48% | 45.01% | 44.39% | 36.12% | 30.45% |
| Research & Development | 99.16M | 101.35M | 83.66M | 49.96M | 42.31M | 35.71M | 31.49M |
| General & Administrative | 62.12M | 81.21M | 99.11M | 31.58M | 26.15M | 19.67M | 21.12M |
| Selling & Marketing | 100.07M | 99.11M | 86.77M | 33.71M | 30.05M | 23.46M | 22.26M |
| SG&A | 162.19M | 180.32M | 185.87M | 65.30M | 56.20M | 43.12M | 43.39M |
| Other Expenses | 45.16M | 46.38M | 42.61M | 8.21M | 8.52M | -90.00K | -26.00K |
| Operating Expenses | 307.20M | 328.05M | 312.14M | 123.46M | 107.03M | 88.22M | 82.85M |
| Cost & Expenses | 528.75M | 526.95M | 481.16M | 217.14M | 180.71M | 148.79M | 136.29M |
| Interest Income | 0.00 | 255.00K | 2.91M | 3.72M | 2.93M | 2.37M | 0.00 |
| Interest Expense | 0.00 | 255.00K | 2.91M | 3.72M | 2.93M | 2.37M | 1.80M |
| Depreciation & Amortization | 45.16M | 47.38M | 42.61M | 8.21M | 8.52M | 9.39M | 7.98M |
| EBITDA | -71.19M | -110.35M | -130.92M | -38.71M | -39.80M | -44.68M | -51.51M |
| EBITDA Ratio | -17.18% | 50.19% | -41.50% | -22.72% | -30.03% | -47.12% | -67.04% |
| Operating Income | -114.45M | 135.90M | -171.14M | -46.78M | -48.20M | -53.98M | -59.46M |
| Operating Income Ratio | -27.63% | 37.42% | -55.20% | -27.46% | -36.38% | -56.93% | -77.39% |
| Total Other Income/Expenses | 15.88M | 240.00K | -3.04M | -3.87M | -3.03M | -2.46M | -1.83M |
| Income Before Tax | -98.57M | -463.27M | -128.76M | -50.65M | -51.24M | -56.44M | -61.29M |
| Income Before Tax Ratio | -23.79% | -127.57% | -41.53% | -29.73% | -38.67% | -59.53% | -79.77% |
| Income Tax Expense | 1.24M | -3.62M | -5.64M | 4.00K | 129.00K | 55.00K | 1.77M |
| Net Income | -99.81M | -459.65M | -123.12M | -50.65M | -51.37M | -56.50M | -61.29M |
| Net Income Ratio | -24.09% | -126.58% | -39.71% | -29.73% | -38.76% | -59.59% | -79.77% |
| EPS | -1.33 | -6.45 | -1.93 | -1.72 | -1.05 | -1.63 | -1.77 |
| EPS Diluted | -1.33 | -6.45 | -1.93 | -1.72 | -1.05 | -1.63 | -1.77 |
| Weighted Avg Shares Out | 74.91M | 71.28M | 63.82M | 29.37M | 48.79M | 34.63M | 34.63M |
| Weighted Avg Shares Out (Dil) | 74.91M | 71.28M | 63.82M | 29.37M | 48.79M | 34.63M | 34.63M |
ACCD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Accolade, Inc. and Encourages Shareholders to Contact the Firm Today!
NEW YORK, NY / ACCESSWIRE / July 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain...
ACCD STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Accolade, Inc. and Encourages Investors to Contact the Firm Today!
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain...
The Schall Law Firm Invites Stakeholders Of Accolade Inc To Join The Potential Securities Fraud Probe
LOS ANGELES, CA / ACCESSWIRE / July 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD) for violations...
Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. (“Accolade” or “the Company”) (NASDAQ: ACCD). Investors who purchased Accolade securities are encouraged...
ACCD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Accolade, Inc. and Encourages Investors to Contact the Firm Today!
NEW YORK, NY / ACCESSWIRE / July 19, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain...
Investors Of Accolade Inc Are Encouraged By The Schall Law Firm To Participate In The Investigation Into Potential Securities Fraud.
LOS ANGELES, CA / ACCESSWIRE / July 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD) for violations...
ACCD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Accolade, Inc. and Encourages Investors to Contact the Firm Today!
NEW YORK, NY / ACCESSWIRE / July 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain...
The Schall Law Firm Encourages Investors Of Accolade Inc To Join The Probe Into Potential Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / July 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD) for violations...
ACCD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Accolade, Inc. and Encourages Stockholders to Contact the Firm!
NEW YORK, NY / ACCESSWIRE / July 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain...
Pernod Ricard to sell bulk of wine portfolio to Accolade Wine owners
Pernod Ricard said on Wednesday it agreed to sell the majority of its wine portfolio to the owners of Australia's Accolade Wines, disposing of a dragging division to focus on its core business of spirits.
Source: https://incomestatements.info
Category: Stock Reports